tucmas.fi BBS

The examine was launched in July 1998 Combinations and S-1 with targeted recruitment of 470 analyzable in Adjuvant Setting patients aiming to detect an increase of general survival from 18 to 25 months by gemcitabine- After 2005, 4 newly adjuvant studies have been containing remedy in intent-to-trea...